Latest stage · inferred · Sat Jan 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Light Wave Holding Company, LLC looks under-valued against its niche peers and is active on financing cadence.
Raised $83M across 20 disclosed rounds, last modeled as Series B (a $15M–$40M round).
Modeled value is 0.13× the median modeled value of Series B Other Health Care companies in 2025–2027 (48 peers) — value vs value, same stage and era.
Valued on the health care profile — its sector's growth and survival benchmarks differ from the market default, so the same raise is worth more or less here.
Last raise 5 mo ago; this sector typically re-raises about every 14 months.
Latest round stepped up 8.3× from the prior — scaling.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Under-valued
Modeled value is 0.13× the median modeled value of Series B Other Health Care companies in 2025–2027 (48 peers) — value vs value, same stage and era.
Active
Last raise 5 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
Issuer-vehicle patternmedium confidence
Light Wave Holding Company, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
9.7 yr record
Peak capital year was 2016 with $26.5M across 1 filings.
Market position
ahead of 95% of Other Health Care peers
Capital scale is ahead of 95% of Other Health Care peers; modeled value is above 37% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
Legal name looks like an issuer vehicle rather than a product company.
No clearly named CEO/founder/principal role in the public records surfaced here.
No verified homepage on the profile yet.
Capital program peaked in 2016: $26.5M across 1 filings.
Largest single filing was $26.5M on 2016-11-01.
How to read the page
Read this less like a startup funding journey and more like a capital-raising program.
Stage-based valuation and peer labels have lower applicability for this pattern.
The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
Where it sits in Other Health Care
Light Wave Holding Company, LLC is one of 5377 Other Health Care companies tracked from NEW YORK. By capital raised it ranks among the largest (ahead of 95% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
US
Jurisdiction
Rule 506(b)
Reg D exemption
35
Investors (latest)
2026-01-31
First sale
Amount raised vs valuation, by round
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
Amount raised · realModeled valuation · estCumulative funded · real
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Financing ladder & sequence gaps
Series B$26.5M · 2016
Series B extension$2.1M · 2018
Series B extension$6.0M · 2018
Series B extension$15.6M · 2019
Series B extension$170K · 2020
Series B extension$200K · 2021
Series B extension$2.2M · 2021
Series B extension$6.4M · 2021
Series B extension$771K · 2022
Series B extension$1.1M · 2023
Series B extension$8.0M · 2024
Series B extension$714K · 2024
Series B extension$317K · 2024
Series B extension$4.1M · 2024
Series B extension$1.5M · 2024
Series B extension$415K · 2024
Series B extension$3.0M · 2025
Series B extension$485K · 2025
Series B extension$350K · 2025
Series B extension$2.9M · 2026
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.
Modeled valuation trajectory
$11.7M
Base estimate est.
$6.8M
Conservative case
$15.5M
Upside case
$16.1M
Modeled post-money
Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
0.4 yr
Elapsed time used
0.4 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$9.0M/yr
Capital velocity
9.7 yr
On record since
2016
First round
20
Rounds on file
How it compares to the market
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Total raised — vs sector median (real $, all stages)▲ 34× above median
This company$82.9M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage)▼ 0.2× of median
This company$2.9M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages)▼ 0.5× of median
This company$11.7M
Sector median$22.1M
Raised more than 95% of sector peers (real $). Modeled value above 37% of peers (estimate).
Niche peers — same stage & era
A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled valueest. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #44 of 48.
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
Stage
Amount · real
Announced
Post-money · est
Value · est
Conf.
Series B
$26.5M
2016-11-01
$147.5M
$588.1M
90%
Series B
$2.1M
2018-07-26
$11.7M
$46.5M
90%
Series B
$6.0M
2018-12-18
$33.3M
$132.9M
90%
Series B
$15.6M
2019-12-06
$86.9M
$346.5M
90%
Series B
$170K
2020-02-14
$944K
$3.8M
90%
Series B
$200K
2021-03-05
$1.1M
$3.6M
90%
Series B
$2.2M
2021-05-03
$12.1M
$37.4M
90%
Series B
$6.4M
2021-10-01
$35.8M
$97.5M
90%
Series B
$771K
2022-02-22
$4.3M
$10.3M
90%
Series B
$1.1M
2023-09-07
$5.9M
$9.0M
90%
Series B
$8.0M
2024-01-30
$44.4M
$59.3M
90%
Series B
$714K
2024-02-28
$4.0M
$5.2M
90%
Series B
$317K
2024-04-22
$1.8M
$2.2M
90%
Series B
$4.1M
2024-06-26
$22.9M
$27.0M
90%
Series B
$1.5M
2024-07-16
$8.5M
$9.9M
90%
Series B
$415K
2024-10-11
$2.3M
$2.5M
90%
Series B
$3.0M
2025-01-30
$16.5M
$16.3M
90%
Series B
$485K
2025-05-23
$2.7M
$2.4M
90%
Series B
$350K
2025-06-10
$1.9M
$1.7M
90%
Series B
$2.9M
2026-01-31
$16.1M
$11.7M
90%
What happened at each round
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Series B$26.5M2016-11-01
First recorded raise — entered as Series B.
8 investors on this round.
Series B$2.1M2018-07-26
Raised again after 21 mo — slower than the ~14 mo sector norm.
Round 12.6× smaller than the prior — bridge or down round.
3 investors on this round.
Series B$6.0M2018-12-18
Came back fast: 5 mo vs the ~14 mo sector norm.
Round 2.9× larger than the prior — scaling up.
18 investors on this round.
Series B$15.6M2019-12-06
Raised 12 mo later, in step with the ~14 mo sector norm.
Round 2.6× larger than the prior — scaling up.
6 investors on this round.
Series B$170K2020-02-14
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 92.0× smaller than the prior — bridge or down round.
1 investor on this round.
Series B$200K2021-03-05
Raised 13 mo later, in step with the ~14 mo sector norm.
Round roughly the size of the prior one.
1 investor on this round.
Series B$2.2M2021-05-03
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 10.9× larger than the prior — scaling up.
2 investors on this round.
Series B$6.4M2021-10-01
Came back fast: 5 mo vs the ~14 mo sector norm.
Round 3.0× larger than the prior — scaling up.
8 investors on this round.
Series B$771K2022-02-22
Came back fast: 5 mo vs the ~14 mo sector norm.
Round 8.4× smaller than the prior — bridge or down round.
1 investor on this round.
Series B$1.1M2023-09-07
Raised 18 mo later, in step with the ~14 mo sector norm.
Round 1.4× larger than the prior — scaling up.
2 investors on this round.
Series B$8.0M2024-01-30
Came back fast: 5 mo vs the ~14 mo sector norm.
Round 7.5× larger than the prior — scaling up.
36 investors on this round.
Series B$714K2024-02-28
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 11.2× smaller than the prior — bridge or down round.
16 investors on this round.
Series B$317K2024-04-22
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 2.3× smaller than the prior — bridge or down round.
25 investors on this round.
Series B$4.1M2024-06-26
Came back fast: 2 mo vs the ~14 mo sector norm.
Round 13.0× larger than the prior — scaling up.
1 investor on this round.
Series B$1.5M2024-07-16
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 2.7× smaller than the prior — bridge or down round.
2 investors on this round.
Series B$415K2024-10-11
Came back fast: 3 mo vs the ~14 mo sector norm.
Round 3.7× smaller than the prior — bridge or down round.
11 investors on this round.
Series B$3.0M2025-01-30
Came back fast: 4 mo vs the ~14 mo sector norm.
Round 7.2× larger than the prior — scaling up.
36 investors on this round.
Series B$485K2025-05-23
Came back fast: 4 mo vs the ~14 mo sector norm.
Round 6.1× smaller than the prior — bridge or down round.
17 investors on this round.
Series B$350K2025-06-10
Came back fast: 1 mo vs the ~14 mo sector norm.
Round 1.4× smaller than the prior — bridge or down round.
1 investor on this round.
Series B$2.9M2026-01-31
Came back fast: 8 mo vs the ~14 mo sector norm.
Round 8.3× larger than the prior — scaling up.
35 investors on this round.
Intelligence
2026 ~Q3
Modeled next raise · ~6mo cadence
$8.7M
Modeled next size est.range $5.7M–$13.9M
8.3×
Last step-up
$9.0M/yr
Capital velocity
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Key people & operators
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
Light Wave Holding Company, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
United States
Country of record
US
Jurisdiction
1688871
SEC CIK
Similar companies
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
How much funding has Light Wave Holding Company, LLC raised?
Light Wave Holding Company, LLC has raised approximately $82.9M in disclosed capital across 20 recorded financing rounds, aggregated from public filings.
What is Light Wave Holding Company, LLC's estimated valuation?
Provath's modeled valuation for Light Wave Holding Company, LLC is approximately $11.7M (modeled range $6.8M–$15.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Light Wave Holding Company, LLC at?
Light Wave Holding Company, LLC's latest modeled financing stage is Series B. Its most recent recorded round closed around Sat Jan 31.
What does Light Wave Holding Company, LLC do and where is it based?
Light Wave Holding Company, LLC operates in the Other Health Care sector, based in NEW YORK.
Explore related
See where Light Wave Holding Company, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at Light Wave Holding Company, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.